Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2026-04-26 @ 10:41 PM
Study NCT ID:
NCT05589818
Status:
RECRUITING
Last Update Posted:
2025-06-25
First Post:
2022-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab for Advanced NSCLC and PS 2-3
Sponsor:
Organization: